China Pharma Holdings, Inc.'s ability to collect accounts receivable sequentially worsen to 3.86, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. China Pharma Holdings's Accounts Receivable average collection period in the Jun 30 2012 quarter, has increased to 95 days, from 91 days, in the Mar 31 2012 quarter.

If we take a look into Healthcare sector 399 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is China Pharma Holdings, Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CHPI Receivables Turnover Ratio	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter	(Jun 30 2011) II. Quarter
Y / Y Receivable Change	-25.1 %	-27.88 %	-	-	-
Y / Y Revenue Change	-34.18 %	-4.59 %	-19 %	35.66 %	-
Receivable Turnover Ratio (TTM)	3.86	4.02	3.82	5.43	7.69
CHPI's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	95	91	96	67	47
Seq. Receivable Change	32.05 %	-41 %	5.29 %	-8.69 %	27.15 %
Seq. Revenue Change	2.9 %	-2.14 %	-17.8 %	-20.48 %	49.15 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 146
Healthcare Sector	# 400
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
4.48	4.17	3.86
(Jun 30 2011)		(Jun 30 2012)

CHPI Company Profile • Back to CHPI Efficiency Comparisons • Compare CHPI Receivables Turnover Ratio to its Competitors

Financial Statements
China Pharma Holdings's Accounts Receivable	$ 2 Millions	Visit CHPI's Balance sheet
China Pharma Holdings's Sales TTM	$ 9 Millions	Visit CHPI's Income Statement
Sources of CHPI's Revenues		Visit CHPI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CHPI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CHPI's Growth Rates	CHPI's Roa	CHPI's Inventory Turnover Ratio	CHPI's Dividend Comparisons
CHPI's Profitability Ratios	CHPI's Roi	CHPI's Asset Turnover Ratio	CHPI's Dividend Growth
CHPI's Valuation Ratios	CHPI's Roe	CHPI's Financial Strength Ratios	CHPI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2012, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2012	Receivable at quarter ending Jun 30 2012
Nanomix Corp	11.27	$ 0.023 Millions	$ 0.002 Millions
Rockwell Medical inc	11.27	$ 48.026 Millions	$ 4.263 Millions
American Caresource Holdings, Inc.	11.22	$ 42.137 Millions	$ 3.757 Millions
Neurometrix Inc	11.19	$ 9.208 Millions	$ 0.823 Millions
International Stem Cell Corporation	11.12	$ 4.036 Millions	$ 0.363 Millions
Apyx Medical Corp	11.09	$ 26.587 Millions	$ 2.397 Millions
Vaso Corporation	10.83	$ 38.255 Millions	$ 3.534 Millions
Neurocrine Biosciences Inc	10.79	$ 74.580 Millions	$ 6.912 Millions
Genomic Health Inc	10.27	$ 221.553 Millions	$ 21.565 Millions
Sonoma Pharmaceuticals Inc	10.15	$ 13.855 Millions	$ 1.365 Millions
Reflect Scientific Inc	10.14	$ 1.589 Millions	$ 0.157 Millions
Inovio Pharmaceuticals Inc	9.98	$ 6.399 Millions	$ 0.642 Millions
Spero Therapeutics Inc	9.85	$ 16.065 Millions	$ 1.631 Millions
Encision Inc	9.85	$ 12.906 Millions	$ 1.311 Millions
Trius Therapeutics Inc	9.84	$ 51.493 Millions	$ 5.235 Millions
Myriad Genetics Inc	9.73	$ 496.005 Millions	$ 51.002 Millions
Antares Pharma Inc	9.69	$ 20.735 Millions	$ 2.140 Millions
Enliven Therapeutics Inc	9.65	$ 0.257 Millions	$ 0.027 Millions
Quidelortho Corp	9.48	$ 140.317 Millions	$ 14.795 Millions
Surmodics Inc	9.34	$ 51.986 Millions	$ 5.567 Millions
Ensign Group Inc	9.33	$ 795.476 Millions	$ 85.226 Millions
Cadence Pharmaceuticals Inc	9.31	$ 28.542 Millions	$ 3.066 Millions
Cumberland Pharmaceuticals Inc	9.26	$ 48.709 Millions	$ 5.261 Millions
Henry Schein Inc	9.21	$ 8,752.312 Millions	$ 950.268 Millions
United Therapeutics Corporation	9.09	$ 826.711 Millions	$ 90.951 Millions
Sanuwave Health Inc	9.05	$ 0.836 Millions	$ 0.092 Millions
Option Care Health Inc	9.03	$ 1,867.148 Millions	$ 206.726 Millions
Vycor Medical Inc	9.03	$ 1.527 Millions	$ 0.169 Millions
Atrion Corporation	8.88	$ 115.904 Millions	$ 13.046 Millions
Mit Holding, Inc.	8.86	$ 4.864 Millions	$ 0.549 Millions

Date modified: 2026-09-02T20:25:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.